Fact CheckerSign in

NCT05699629Recruiting

Prospective Coronary Heart Disease Cohort

A Prospective Longitudinal Multi-Omics Cohort of Patients With Coronary Heart Disease Undergoing Coronary Angiography

Source: ClinicalTrials.gov · Last updated 13 Feb 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

To evaluate the biomarkers for the prognosis of coronary heart disease, patients with coronary heart disease will be recruited and followed up for at least 2 years.

Status (registry)
Recruiting
Study type
Observational
Enrollment
50000 (estimated)
First submitted
9 Jan 2023
Start date
21 Jan 2022
Primary completion date
21 Jan 2027
Lead sponsor
Shandong First Medical University
NCT number
NCT05699629

What you commit to

  • Study type: Observational
  • Planned participants: 50000
  • From 21 Jan 2022 to the primary completion date, 21 Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • With malignant tumors, infectious diseases and advanced liver diseases.

Other

  • Won't sign an inform consent.

Who the study is looking for

  • Diagnosed as coronary heart disease or with unexplained chest pain needed to undergo coronary angiography.
  • Healthy subjects undergoing routine physical examination in the physical examination department and willing to sign informed consent will be recruited as control subjects.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Shandong First Medical University
Coordinator of this site? Confirm its status
JinanChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.